Canton Strategic Holdings (CNTN) Enterprise Value Growth (1y) (2021 - 2026)
Canton Strategic Holdings (CNTN) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,760.12% |
| Dec 31, 2025 | -378.53% |
| Sep 30, 2025 | -59.40% |
| Jun 30, 2025 | 71.61% |
| Mar 31, 2025 | 87.23% |
| Dec 31, 2024 | 67.45% |
| Sep 30, 2024 | -77.54% |
| Jun 30, 2024 | -102.25% |
| Mar 31, 2024 | -136.11% |
| Dec 31, 2023 | -67.96% |
| Sep 30, 2023 | 64.60% |
| Jun 30, 2023 | 58.84% |
| Mar 31, 2023 | 67.91% |
| Dec 31, 2022 | -149,361.29% |
| Sep 30, 2022 | -16,745.92% |
| Jun 30, 2022 | -32,301.30% |
| Mar 31, 2022 | -49,315.09% |
| Dec 31, 2021 | 97.73% |